SK

Sudhir Kumar Dhaple

Active Director Director DIN 06974675
DIN 06974675 First appointment Oct 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudhir Kumar Dhaple

Data last updated:

Sudhir Kumar Dhaple is a Director at Ista Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals.

DIN 06974675
Primary Designation Director
Industry Chemicals
First Appointment 17 Oct 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ista Pharmaceuticals Private Limited U24232MP2014PTC033325
Director17 Oct 20142014Dormant Under Section 455

Board colleagues of Sudhir Kumar Dhaple

Directorship timeline

Open interactive timeline →
Ista Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sudhir Kumar Dhaple

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Kumar Dhaple

Sudhir Kumar Dhaple currently holds 1 directorship: Ista Pharmaceuticals Private Limited (Director, since 17 Oct 2014).

Sudhir Kumar Dhaple was first appointed on 17 Oct 2014 as Director at Ista Pharmaceuticals Private Limited.

The current boards of Sudhir Kumar Dhaple's companies include Kashif Ahmed (Ista Pharmaceuticals Private Limited), Rajesh Kumar Singh (Ista Pharmaceuticals Private Limited), Vivek Sharma (Ista Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available